Reporting Manager
Steven A. Cohen
Symbol
LENZ
Shares outstanding
28,286,479 shares
Disclosed Ownership
1,357,751 shares
Ownership
4.8%
Form type
SCHEDULE 13G/A
Filing time
14 Nov 2025, 16:03:42 UTC
Date of event
30 Sep 2025

Quoteable Key Fact

"Point72 Asset Management, L.P. disclosed 4.8% ownership in LENZ Therapeutics, Inc. Common Stock, par value $0.00001 per share (LENZ) on 30 Sep 2025."

Quick Takeaways

  • Point72 Asset Management, L.P. filed SCHEDULE 13G/A for LENZ Therapeutics, Inc. Common Stock, par value $0.00001 per share (LENZ).
  • Disclosed ownership: 4.8%.
  • Date of event: 30 Sep 2025.

What Changed

  • No earlier schedule filing is available for direct comparison.
  • Current filing was accepted on 14 Nov 2025, 16:03.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Source Evidence

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (6)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Point72 Asset Management, L.P. 1.2% 340,000 0 340,000 /s/ Jason M. Colombo Jason M. Colombo, Authorized Person
Point72 Capital Advisors, Inc. 1.2% 340,000 0 340,000 /s/ Jason M. Colombo Jason M. Colombo, Authorized Person
Point72 Biotech Private Investments, LLC 3.6% 1,017,751 0 1,017,751 /s/ Vincent Tortorella Vincent Tortorella, Authorized Person
Differentiated Ventures Investments, LLC 3.6% 1,017,751 0 1,017,751 /s/ Vincent Tortorella Vincent Tortorella, Authorized Person
72 Investment Holdings, LLC 3.6% 1,017,751 0 1,017,751 /s/ Jason M. Colombo Jason M. Colombo, Authorized Person
Steven A. Cohen 4.8% 1,357,751 0 1,357,751 /s/ Jason M. Colombo Jason M. Colombo, Authorized Person